Access the full text.
Sign up today, get DeepDyve free for 14 days.
(SovaniMPWhaleCIOborneJCooperSMortimerKPoor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?Br J Gen Pract20083374310.3399/bjgp08X26380218186995)
SovaniMPWhaleCIOborneJCooperSMortimerKPoor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?Br J Gen Pract20083374310.3399/bjgp08X26380218186995SovaniMPWhaleCIOborneJCooperSMortimerKPoor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?Br J Gen Pract20083374310.3399/bjgp08X26380218186995, SovaniMPWhaleCIOborneJCooperSMortimerKPoor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?Br J Gen Pract20083374310.3399/bjgp08X26380218186995
(EdwardsSJGruffydd-JonesKRyanDPSystematic review and meta-analysis of budesonide/formoterol in a single inhalerCurr Med Res Opin200731809182010.1185/030079907X21069717597557)
EdwardsSJGruffydd-JonesKRyanDPSystematic review and meta-analysis of budesonide/formoterol in a single inhalerCurr Med Res Opin200731809182010.1185/030079907X21069717597557EdwardsSJGruffydd-JonesKRyanDPSystematic review and meta-analysis of budesonide/formoterol in a single inhalerCurr Med Res Opin200731809182010.1185/030079907X21069717597557, EdwardsSJGruffydd-JonesKRyanDPSystematic review and meta-analysis of budesonide/formoterol in a single inhalerCurr Med Res Opin200731809182010.1185/030079907X21069717597557
(DescalziDFolliCNicoliniGRiccioAMGamaleroCScordamagliaFCanonicaGWAnti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblastsAllergy2008343243710.1111/j.1398-9995.2007.01582.x18076728)
DescalziDFolliCNicoliniGRiccioAMGamaleroCScordamagliaFCanonicaGWAnti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblastsAllergy2008343243710.1111/j.1398-9995.2007.01582.x18076728DescalziDFolliCNicoliniGRiccioAMGamaleroCScordamagliaFCanonicaGWAnti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblastsAllergy2008343243710.1111/j.1398-9995.2007.01582.x18076728, DescalziDFolliCNicoliniGRiccioAMGamaleroCScordamagliaFCanonicaGWAnti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblastsAllergy2008343243710.1111/j.1398-9995.2007.01582.x18076728
M. Kraft, E. Israel, G. O'Connor (2007)
Clinical Decisions. Treatment of mild persistent asthma.The New England journal of medicine, 356 20
(PapiAPaggiaroPLNicoliniGVignolaAMFabbriLMBeclomethasone/formoterol versus budesonide/formoterol combination therapy in asthmaEur Respir J2007368268910.1183/09031936.0009590617107988)
PapiAPaggiaroPLNicoliniGVignolaAMFabbriLMBeclomethasone/formoterol versus budesonide/formoterol combination therapy in asthmaEur Respir J2007368268910.1183/09031936.0009590617107988PapiAPaggiaroPLNicoliniGVignolaAMFabbriLMBeclomethasone/formoterol versus budesonide/formoterol combination therapy in asthmaEur Respir J2007368268910.1183/09031936.0009590617107988, PapiAPaggiaroPLNicoliniGVignolaAMFabbriLMBeclomethasone/formoterol versus budesonide/formoterol combination therapy in asthmaEur Respir J2007368268910.1183/09031936.0009590617107988
D. Price, A. Wirén, P. Kuna (2007)
Cost‐effectiveness of budesonide/formoterol for maintenance and reliever asthma therapyAllergy, 62
(O'ByrnePMBisgaardHGodardPPPistolesiMPalmqvistBudesonide/formoterol combination therapy as both maintenance and reliever medication in asthmaAm J Respir Crit Care Med2005312913610.1164/rccm.200407-884OC15502112)
O'ByrnePMBisgaardHGodardPPPistolesiMPalmqvistBudesonide/formoterol combination therapy as both maintenance and reliever medication in asthmaAm J Respir Crit Care Med2005312913610.1164/rccm.200407-884OC15502112O'ByrnePMBisgaardHGodardPPPistolesiMPalmqvistBudesonide/formoterol combination therapy as both maintenance and reliever medication in asthmaAm J Respir Crit Care Med2005312913610.1164/rccm.200407-884OC15502112, O'ByrnePMBisgaardHGodardPPPistolesiMPalmqvistBudesonide/formoterol combination therapy as both maintenance and reliever medication in asthmaAm J Respir Crit Care Med2005312913610.1164/rccm.200407-884OC15502112
P. Program., Third theDiagnosis (1997)
Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma
J. FitzGerald (1998)
Effect of inhaled formoterol and budesonide on exacerbations of asthma.The New England journal of medicine, 338 15
(2008)
Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts
(BaouzSGiron-MichelJAzzaroneBGiulianiMCagnoniFLung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of alpha-SMA and NF-kappaBInt Immunol200531473148110.1093/intimm/dxh32516210331)
BaouzSGiron-MichelJAzzaroneBGiulianiMCagnoniFLung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of alpha-SMA and NF-kappaBInt Immunol200531473148110.1093/intimm/dxh32516210331BaouzSGiron-MichelJAzzaroneBGiulianiMCagnoniFLung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of alpha-SMA and NF-kappaBInt Immunol200531473148110.1093/intimm/dxh32516210331, BaouzSGiron-MichelJAzzaroneBGiulianiMCagnoniFLung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of alpha-SMA and NF-kappaBInt Immunol200531473148110.1093/intimm/dxh32516210331
(RabeKFAtienzaTMagyarPLarssonPJorupCLallooUGEffect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind studyLancet2006374475310.1016/S0140-6736(06)69284-216935685)
RabeKFAtienzaTMagyarPLarssonPJorupCLallooUGEffect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind studyLancet2006374475310.1016/S0140-6736(06)69284-216935685RabeKFAtienzaTMagyarPLarssonPJorupCLallooUGEffect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind studyLancet2006374475310.1016/S0140-6736(06)69284-216935685, RabeKFAtienzaTMagyarPLarssonPJorupCLallooUGEffect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind studyLancet2006374475310.1016/S0140-6736(06)69284-216935685
V. Balanag, F. Yunus, P-C. Yang, C. Jorup (2006)
Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma.Pulmonary pharmacology & therapeutics, 19 2
A. Tattersfield, D. Postma, P. Barnes, K. Svensson, Carl-Axel Bauer, P. O'Byrne, C. Löfdahl, R. Pauwels, A. Ullman (1999)
Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group.American journal of respiratory and critical care medicine, 160 2
H. Petsky, J. Kynaston, C. Turner, A. Li, C. Cates, T. Lasserson, A. Chang (2007)
Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.The Cochrane database of systematic reviews, 2
(Global Initiative for Asthma (GINA)Global Strategy for the Asthma Management and Prevention2008http://www.ginasthma.org)
Global Initiative for Asthma (GINA)Global Strategy for the Asthma Management and Prevention2008http://www.ginasthma.orgGlobal Initiative for Asthma (GINA)Global Strategy for the Asthma Management and Prevention2008http://www.ginasthma.org, Global Initiative for Asthma (GINA)Global Strategy for the Asthma Management and Prevention2008http://www.ginasthma.org
(BousheyHASorknessCAKingTSSullivanSDFahyJVDaily versus as-needed corticosteroids for mild persistent asthmaN Engl Med200531519152810.1056/NEJMoa042552)
BousheyHASorknessCAKingTSSullivanSDFahyJVDaily versus as-needed corticosteroids for mild persistent asthmaN Engl Med200531519152810.1056/NEJMoa042552BousheyHASorknessCAKingTSSullivanSDFahyJVDaily versus as-needed corticosteroids for mild persistent asthmaN Engl Med200531519152810.1056/NEJMoa042552, BousheyHASorknessCAKingTSSullivanSDFahyJVDaily versus as-needed corticosteroids for mild persistent asthmaN Engl Med200531519152810.1056/NEJMoa042552
(CazesEGiron-MichelJBaouzSDoucetCCagnoniFNovel anti-inflammatory effects of the inhaled corticosteroid fluticasone propionate during lung myofibroblastic differentiationJ Immunol200135329533711673549)
CazesEGiron-MichelJBaouzSDoucetCCagnoniFNovel anti-inflammatory effects of the inhaled corticosteroid fluticasone propionate during lung myofibroblastic differentiationJ Immunol200135329533711673549CazesEGiron-MichelJBaouzSDoucetCCagnoniFNovel anti-inflammatory effects of the inhaled corticosteroid fluticasone propionate during lung myofibroblastic differentiationJ Immunol200135329533711673549, CazesEGiron-MichelJBaouzSDoucetCCagnoniFNovel anti-inflammatory effects of the inhaled corticosteroid fluticasone propionate during lung myofibroblastic differentiationJ Immunol200135329533711673549
E. Cazes, J. Giron-Michel, S. Baouz, C. Doucet, F. Cagnoni, S. Oddera, M. Körner, G. Dašić, R. Testi, B. Azzarone, G. Canonica (2001)
Novel Anti-inflammatory Effects of the Inhaled Corticosteroid Fluticasone Propionate During Lung Myofibroblastic Differentiation1The Journal of Immunology, 167
(2003)
British guideline on the management of asthma.Thorax, 58 Suppl 1
(PapiAPaggiaroPNicoliniGVignolaAMFabbriLMBeclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthmaAllergy200731182118810.1111/j.1398-9995.2007.01493.x17845589)
PapiAPaggiaroPNicoliniGVignolaAMFabbriLMBeclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthmaAllergy200731182118810.1111/j.1398-9995.2007.01493.x17845589PapiAPaggiaroPNicoliniGVignolaAMFabbriLMBeclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthmaAllergy200731182118810.1111/j.1398-9995.2007.01493.x17845589, PapiAPaggiaroPNicoliniGVignolaAMFabbriLMBeclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthmaAllergy200731182118810.1111/j.1398-9995.2007.01493.x17845589
(PapiACanonicaGWMaestrelliPPaggiaroPOlivieriDRescue use of beclomethasone and albuterol in a single inhaler for mild asthmaN Engl J Med200732040205210.1056/NEJMoa06386117507703)
PapiACanonicaGWMaestrelliPPaggiaroPOlivieriDRescue use of beclomethasone and albuterol in a single inhaler for mild asthmaN Engl J Med200732040205210.1056/NEJMoa06386117507703PapiACanonicaGWMaestrelliPPaggiaroPOlivieriDRescue use of beclomethasone and albuterol in a single inhaler for mild asthmaN Engl J Med200732040205210.1056/NEJMoa06386117507703, PapiACanonicaGWMaestrelliPPaggiaroPOlivieriDRescue use of beclomethasone and albuterol in a single inhaler for mild asthmaN Engl J Med200732040205210.1056/NEJMoa06386117507703
(PetskyHLKynastonJATurnerCLiAMCatesCJLassersonTJChangABTailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adultsCochrane Database Syst Rev20073CD00560317443604)
PetskyHLKynastonJATurnerCLiAMCatesCJLassersonTJChangABTailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adultsCochrane Database Syst Rev20073CD00560317443604PetskyHLKynastonJATurnerCLiAMCatesCJLassersonTJChangABTailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adultsCochrane Database Syst Rev20073CD00560317443604, PetskyHLKynastonJATurnerCLiAMCatesCJLassersonTJChangABTailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adultsCochrane Database Syst Rev20073CD00560317443604
(WraightJMSmithADCowanJOFlanneryEMHerbisonGPTaylorDRAdverse effects of short-acting beta-agonists: potential impact when anti-inflammatory therapy is inadequateRespirology2004321522110.1111/j.1440-1843.2004.00557.x15182272)
WraightJMSmithADCowanJOFlanneryEMHerbisonGPTaylorDRAdverse effects of short-acting beta-agonists: potential impact when anti-inflammatory therapy is inadequateRespirology2004321522110.1111/j.1440-1843.2004.00557.x15182272WraightJMSmithADCowanJOFlanneryEMHerbisonGPTaylorDRAdverse effects of short-acting beta-agonists: potential impact when anti-inflammatory therapy is inadequateRespirology2004321522110.1111/j.1440-1843.2004.00557.x15182272, WraightJMSmithADCowanJOFlanneryEMHerbisonGPTaylorDRAdverse effects of short-acting beta-agonists: potential impact when anti-inflammatory therapy is inadequateRespirology2004321522110.1111/j.1440-1843.2004.00557.x15182272
L. Jayaram, M. Pizzichini, Richard Cook, L. Boulet, C. Lemière, E. Pizzichini, A. Cartier, P. Hussack, Charles Goldsmith, M. Laviolette, K. Parameswaran, F. Hargreave (2006)
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbationsEuropean Respiratory Journal, 27
J. Chlumsky, I. Stříž, M. Teřl, J. Vondráček (2006)
Strategy Aimed at Reduction of Sputum Eosinophils Decreases Exacerbation Rate in Patients with AsthmaJournal of International Medical Research, 34
(National Asthma Education and Prevention ProgramExpert Panel Report 3 Guidelines for the diagnosis and management of asthma2007National Heart, Lung, and Blood Institutehttp://www.nhlbi.nih.gov/guidelines/asthma/)
National Asthma Education and Prevention ProgramExpert Panel Report 3 Guidelines for the diagnosis and management of asthma2007National Heart, Lung, and Blood Institutehttp://www.nhlbi.nih.gov/guidelines/asthma/National Asthma Education and Prevention ProgramExpert Panel Report 3 Guidelines for the diagnosis and management of asthma2007National Heart, Lung, and Blood Institutehttp://www.nhlbi.nih.gov/guidelines/asthma/, National Asthma Education and Prevention ProgramExpert Panel Report 3 Guidelines for the diagnosis and management of asthma2007National Heart, Lung, and Blood Institutehttp://www.nhlbi.nih.gov/guidelines/asthma/
R. Pauwels, C. Löfdahl, D. Postma, A. Tattersfield, P. O'Byrne, P. Barnes, A. Ullman (1997)
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.The New England journal of medicine, 337 20
G. Currie, Daniel Lee, B. Lipworth (2006)
Long-acting beta2-agonists in asthma: not so SMART?Drug safety, 29 8
G. Currie, Daniel Lee, B. Lipworth (2006)
Long-Acting β2-Agonists in AsthmaDrug Safety, 29
(CurrieGPLeeDKLipworthBJLong-acting beta2-agonists in asthma: not so SMART?Drug Saf2006364765610.2165/00002018-200629080-0000216872239)
CurrieGPLeeDKLipworthBJLong-acting beta2-agonists in asthma: not so SMART?Drug Saf2006364765610.2165/00002018-200629080-0000216872239CurrieGPLeeDKLipworthBJLong-acting beta2-agonists in asthma: not so SMART?Drug Saf2006364765610.2165/00002018-200629080-0000216872239, CurrieGPLeeDKLipworthBJLong-acting beta2-agonists in asthma: not so SMART?Drug Saf2006364765610.2165/00002018-200629080-0000216872239
M. Profita, R. Gagliardo, R. Giorgi, F. Pompeo, M. Gjomarkaj, Gabriele Nicolini, Jean Bousquet, A. Vignola, A. Vignola (2005)
Biochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmaticsAllergy, 60
(GreenRHBrightlingCEMcKennaSHargadonBParkerDAsthma exacerbations and sputum eosinophil counts: a randomised controlled trialLancet200231715172110.1016/S0140-6736(02)11679-512480423)
GreenRHBrightlingCEMcKennaSHargadonBParkerDAsthma exacerbations and sputum eosinophil counts: a randomised controlled trialLancet200231715172110.1016/S0140-6736(02)11679-512480423GreenRHBrightlingCEMcKennaSHargadonBParkerDAsthma exacerbations and sputum eosinophil counts: a randomised controlled trialLancet200231715172110.1016/S0140-6736(02)11679-512480423, GreenRHBrightlingCEMcKennaSHargadonBParkerDAsthma exacerbations and sputum eosinophil counts: a randomised controlled trialLancet200231715172110.1016/S0140-6736(02)11679-512480423
Alberto Papi, P. Paggiaro, G. Nicolini, A. Vignola, Leonardo Fabbri (2007)
Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthmaEuropean Respiratory Journal, 29
(JayaramLPizzichiniMMCookRJBouletLPLemiereCDetermining asthma treatment by monitoring sputum cell counts: effect on exacerbationsEur Respir J2006348349410.1183/09031936.06.0013770416507847)
JayaramLPizzichiniMMCookRJBouletLPLemiereCDetermining asthma treatment by monitoring sputum cell counts: effect on exacerbationsEur Respir J2006348349410.1183/09031936.06.0013770416507847JayaramLPizzichiniMMCookRJBouletLPLemiereCDetermining asthma treatment by monitoring sputum cell counts: effect on exacerbationsEur Respir J2006348349410.1183/09031936.06.0013770416507847, JayaramLPizzichiniMMCookRJBouletLPLemiereCDetermining asthma treatment by monitoring sputum cell counts: effect on exacerbationsEur Respir J2006348349410.1183/09031936.06.0013770416507847
(British Thoracic Society/Scottish Intercollegiate Guidelines NetworkBritish Guideline on the Management of AsthmaJune 2009 update. Accessed at www.brit-thoracic.org.uk)
British Thoracic Society/Scottish Intercollegiate Guidelines NetworkBritish Guideline on the Management of AsthmaJune 2009 update. Accessed at www.brit-thoracic.org.ukBritish Thoracic Society/Scottish Intercollegiate Guidelines NetworkBritish Guideline on the Management of AsthmaJune 2009 update. Accessed at www.brit-thoracic.org.uk, British Thoracic Society/Scottish Intercollegiate Guidelines NetworkBritish Guideline on the Management of AsthmaJune 2009 update. Accessed at www.brit-thoracic.org.uk
(SwystunVAGordonJRDavisEBZhangXCockcroftDWMast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamolJ Allergy Clin Immunol20003576410.1067/mai.2000.10739610887306)
SwystunVAGordonJRDavisEBZhangXCockcroftDWMast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamolJ Allergy Clin Immunol20003576410.1067/mai.2000.10739610887306SwystunVAGordonJRDavisEBZhangXCockcroftDWMast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamolJ Allergy Clin Immunol20003576410.1067/mai.2000.10739610887306, SwystunVAGordonJRDavisEBZhangXCockcroftDWMast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamolJ Allergy Clin Immunol20003576410.1067/mai.2000.10739610887306
(PartridgeMRvan derMTMyrsethSEBusseWWAttitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE studyBMC Pulm Med200631310.1186/1471-2466-6-1316772035)
PartridgeMRvan derMTMyrsethSEBusseWWAttitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE studyBMC Pulm Med200631310.1186/1471-2466-6-1316772035PartridgeMRvan derMTMyrsethSEBusseWWAttitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE studyBMC Pulm Med200631310.1186/1471-2466-6-1316772035, PartridgeMRvan derMTMyrsethSEBusseWWAttitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE studyBMC Pulm Med200631310.1186/1471-2466-6-1316772035
A. Papi, P. Paggiaro, G. Nicolini, A. Vignola, L. Fabbri (2007)
Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthmaAllergy, 62
S. Baouz, J. Giron-Michel, B. Azzarone, M. Giuliani, F. Cagnoni, S. Olsson, R. Testi, G. Gabbiani, G. Canonica (2005)
Lung myofibroblasts as targets of salmeterol and fluticasone propionate : inhibition of α-SMA and NF-κBInternational Immunology, 17
Jonathan Wraight, Andrew Smith, J. Cowan, E. Flannery, G. Herbison, D. Taylor (2004)
Adverse effects of short‐acting beta‐agonists: Potential impact when anti‐inflammatory therapy is inadequateRespirology, 9
R. Green, C. Brightling, S. Mckenna, B. Hargadon, D. Parker, P. Bradding, A. Wardlaw, I. Pavord (2002)
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trialThe Lancet, 360
P. Kuna, M. Peters, A. Manjra, C. Jorup, I. Naya, N. Martínez-Jiménez, R. Buhl (2007)
Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbationsInternational Journal of Clinical Practice, 61
(ChlumskýJStrizITerlMVondracekJStrategy aimed at reduction of sputum eosinophils decreases exacerbation rate in patients with asthmaJ Int Med Res2006312913910.1177/14732300060340020216749408)
ChlumskýJStrizITerlMVondracekJStrategy aimed at reduction of sputum eosinophils decreases exacerbation rate in patients with asthmaJ Int Med Res2006312913910.1177/14732300060340020216749408ChlumskýJStrizITerlMVondracekJStrategy aimed at reduction of sputum eosinophils decreases exacerbation rate in patients with asthmaJ Int Med Res2006312913910.1177/14732300060340020216749408, ChlumskýJStrizITerlMVondracekJStrategy aimed at reduction of sputum eosinophils decreases exacerbation rate in patients with asthmaJ Int Med Res2006312913910.1177/14732300060340020216749408
(PauwelsRALofdahlC-GPostmaDSTattersfieldAEO'ByrnePMBarnesPJUllmanAEffect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapye (FACET) International Study GroupN Engl J Med199731405141110.1056/NEJM1997111333720019358137)
PauwelsRALofdahlC-GPostmaDSTattersfieldAEO'ByrnePMBarnesPJUllmanAEffect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapye (FACET) International Study GroupN Engl J Med199731405141110.1056/NEJM1997111333720019358137PauwelsRALofdahlC-GPostmaDSTattersfieldAEO'ByrnePMBarnesPJUllmanAEffect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapye (FACET) International Study GroupN Engl J Med199731405141110.1056/NEJM1997111333720019358137, PauwelsRALofdahlC-GPostmaDSTattersfieldAEO'ByrnePMBarnesPJUllmanAEffect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapye (FACET) International Study GroupN Engl J Med199731405141110.1056/NEJM1997111333720019358137
(SinDDManJSharpeHGanWQManSFPharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysisJAMA2004336737610.1001/jama.292.3.36715265853)
SinDDManJSharpeHGanWQManSFPharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysisJAMA2004336737610.1001/jama.292.3.36715265853SinDDManJSharpeHGanWQManSFPharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysisJAMA2004336737610.1001/jama.292.3.36715265853, SinDDManJSharpeHGanWQManSFPharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysisJAMA2004336737610.1001/jama.292.3.36715265853
F. Spoelstra, D. Postma, H. Hovenga, J. Noordhoek, H. Kauffman (2002)
Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblastsThorax, 57
Bradley Chipps (2006)
Daily Versus As-Needed Corticosteroids for Mild Persistent AsthmaPediatrics, 118
(KraftMIsraelEO'ConnorGTClinical decisions. Treatment of mild persistent asthmaN Engl J Med200732096210017507711)
KraftMIsraelEO'ConnorGTClinical decisions. Treatment of mild persistent asthmaN Engl J Med200732096210017507711KraftMIsraelEO'ConnorGTClinical decisions. Treatment of mild persistent asthmaN Engl J Med200732096210017507711, KraftMIsraelEO'ConnorGTClinical decisions. Treatment of mild persistent asthmaN Engl J Med200732096210017507711
(BergeronCBouletLPStructural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulationChest200631068108710.1378/chest.129.4.106816608960)
BergeronCBouletLPStructural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulationChest200631068108710.1378/chest.129.4.106816608960BergeronCBouletLPStructural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulationChest200631068108710.1378/chest.129.4.106816608960, BergeronCBouletLPStructural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulationChest200631068108710.1378/chest.129.4.106816608960
(KunaPPetersMJManjraAIJorupCNayaIPMartinez-JimenezNEBuhlREffect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbationsInt J Clin Pract2007372573610.1111/j.1742-1241.2007.01338.x17362472)
KunaPPetersMJManjraAIJorupCNayaIPMartinez-JimenezNEBuhlREffect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbationsInt J Clin Pract2007372573610.1111/j.1742-1241.2007.01338.x17362472KunaPPetersMJManjraAIJorupCNayaIPMartinez-JimenezNEBuhlREffect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbationsInt J Clin Pract2007372573610.1111/j.1742-1241.2007.01338.x17362472, KunaPPetersMJManjraAIJorupCNayaIPMartinez-JimenezNEBuhlREffect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbationsInt J Clin Pract2007372573610.1111/j.1742-1241.2007.01338.x17362472
(PriceDWirenAKunaPCost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapyAllergy200731189119810.1111/j.1398-9995.2007.01466.x17845590)
PriceDWirenAKunaPCost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapyAllergy200731189119810.1111/j.1398-9995.2007.01466.x17845590PriceDWirenAKunaPCost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapyAllergy200731189119810.1111/j.1398-9995.2007.01466.x17845590, PriceDWirenAKunaPCost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapyAllergy200731189119810.1111/j.1398-9995.2007.01466.x17845590
P. O'Byrne, H. Bisgaard, P. Godard, M. Pistolesi, M. Palmqvist, Yuan-jue Zhu, T. Ekström, E. Bateman (2005)
Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma.American journal of respiratory and critical care medicine, 171 2
M. Partridge, T. Molen, Sven-Erik Myrseth, W. Busse (2006)
Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE studyBMC Pulmonary Medicine, 6
(SpoelstraFMPostmaDSHovengaHNoordhoekJAKauffmanHFAdditive anti-inflammatory effect of formoterol and budesonide on human lung fibroblastsThorax2002323724110.1136/thorax.57.3.23711867828)
SpoelstraFMPostmaDSHovengaHNoordhoekJAKauffmanHFAdditive anti-inflammatory effect of formoterol and budesonide on human lung fibroblastsThorax2002323724110.1136/thorax.57.3.23711867828SpoelstraFMPostmaDSHovengaHNoordhoekJAKauffmanHFAdditive anti-inflammatory effect of formoterol and budesonide on human lung fibroblastsThorax2002323724110.1136/thorax.57.3.23711867828, SpoelstraFMPostmaDSHovengaHNoordhoekJAKauffmanHFAdditive anti-inflammatory effect of formoterol and budesonide on human lung fibroblastsThorax2002323724110.1136/thorax.57.3.23711867828
(BalanagVMYunusFYangPCJorupCEfficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthmaPulm Pharmacol Ther2006313914710.1016/j.pupt.2005.04.00916009588)
BalanagVMYunusFYangPCJorupCEfficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthmaPulm Pharmacol Ther2006313914710.1016/j.pupt.2005.04.00916009588BalanagVMYunusFYangPCJorupCEfficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthmaPulm Pharmacol Ther2006313914710.1016/j.pupt.2005.04.00916009588, BalanagVMYunusFYangPCJorupCEfficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthmaPulm Pharmacol Ther2006313914710.1016/j.pupt.2005.04.00916009588
S. Baouz, J. Giron-Michel, B. Azzarone, M. Giuliani, F. Cagnoni, S. Olsson, R. Testi, G. Gabbiani, G. Canonica (2005)
Lung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of alpha-SMA and NF-kappaB.International immunology, 17 11
D. Sin, J. Man, H. Sharpe, W. Gan, S. Man (2004)
Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis.JAMA, 292 3
V. Swystun, J. Gordon, E. Davis, Xiaobei Zhang, D. Cockcroft (2000)
Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.The Journal of allergy and clinical immunology, 106 1 Pt 1
M. Sovani, C. Whale, J. Oborne, S. Cooper, K. Mortimer, T. Ekström, A. Tattersfield, T. Harrison (2008)
Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?The British journal of general practice : the journal of the Royal College of General Practitioners, 58 546
A. Papi, G. Canonica, P. Maestrelli, P. Paggiaro, D. Olivieri, E. Pozzi, N. Crimi, A. Vignola, P. Morelli, G. Nicolini, L. Fabbri (2007)
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.The New England journal of medicine, 356 20
P. Barnes (2007)
Scientific rationale for using a single inhaler for asthma controlEuropean Respiratory Journal, 29
K. Rabe, T. Atienza, P. Magyar, P. Larsson, C. Jorup, U. Lalloo (2006)
Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind studyThe Lancet, 368
(TattersfieldAEPostmaDSBarnesPJSvenssonKBauerCAExacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study GroupAm J Respir Crit Care Med1999359459910.1164/ajrccm.160.2.981110010430734)
TattersfieldAEPostmaDSBarnesPJSvenssonKBauerCAExacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study GroupAm J Respir Crit Care Med1999359459910.1164/ajrccm.160.2.981110010430734TattersfieldAEPostmaDSBarnesPJSvenssonKBauerCAExacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study GroupAm J Respir Crit Care Med1999359459910.1164/ajrccm.160.2.981110010430734, TattersfieldAEPostmaDSBarnesPJSvenssonKBauerCAExacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study GroupAm J Respir Crit Care Med1999359459910.1164/ajrccm.160.2.981110010430734
(OborneJMortimerKHubbardRBTattersfieldAEHarrisonTWQuadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trialAm J Respir Crit Care Med2009359860210.1164/rccm.200904-0616OC19590019)
OborneJMortimerKHubbardRBTattersfieldAEHarrisonTWQuadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trialAm J Respir Crit Care Med2009359860210.1164/rccm.200904-0616OC19590019OborneJMortimerKHubbardRBTattersfieldAEHarrisonTWQuadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trialAm J Respir Crit Care Med2009359860210.1164/rccm.200904-0616OC19590019, OborneJMortimerKHubbardRBTattersfieldAEHarrisonTWQuadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trialAm J Respir Crit Care Med2009359860210.1164/rccm.200904-0616OC19590019
(BarnesPJScientific rationale for using a single inhaler for asthma controlEur Respir J2007358759510.1183/09031936.0008030617329493)
BarnesPJScientific rationale for using a single inhaler for asthma controlEur Respir J2007358759510.1183/09031936.0008030617329493BarnesPJScientific rationale for using a single inhaler for asthma controlEur Respir J2007358759510.1183/09031936.0008030617329493, BarnesPJScientific rationale for using a single inhaler for asthma controlEur Respir J2007358759510.1183/09031936.0008030617329493
C. Bergeron, L. Boulet (2006)
Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation.Chest, 129 4
S. Edwards, K. Gruffydd-Jones, D. Ryan (2007)
Systematic review and meta-analysis of budesonide/formoterol in a single inhalerCurrent Medical Research and Opinion, 23
J. Oborne, K. Mortimer, R. Hubbard, A. Tattersfield, T. Harrison (2009)
Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trial.American journal of respiratory and critical care medicine, 180 7
(ProfitaMGagliardoRDiGRPompeoFGjomarkajMBiochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmaticsAllergy2005332332910.1111/j.1398-9995.2005.00702.x15679717)
ProfitaMGagliardoRDiGRPompeoFGjomarkajMBiochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmaticsAllergy2005332332910.1111/j.1398-9995.2005.00702.x15679717ProfitaMGagliardoRDiGRPompeoFGjomarkajMBiochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmaticsAllergy2005332332910.1111/j.1398-9995.2005.00702.x15679717, ProfitaMGagliardoRDiGRPompeoFGjomarkajMBiochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmaticsAllergy2005332332910.1111/j.1398-9995.2005.00702.x15679717
Despite positive clinical experience and the published clinical benefits of monotherapy with low-or medium-dose inhaled corticosteroids or combination therapy with ICS + long-acting beta-agonist to treat asthma, many patients remain suboptimally controlled. Alternative approaches are needed, and 3 options that have had some success are: 1) using the patient's level of inflammation by established biomarkers to set treatment; 2) self-management incorporating flexible dosing; and 3) using a single inhaler for rescue and maintenance therapy. Which strategy for which patient depends ultimately on the individual patient's disease burden, life-style, comorbidities, preferences, and his or her ability to self-manage the disease, including assessing symptoms and adhering with therapy.
World Allergy Organization Journal – Springer Journals
Published: Feb 15, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.